相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation
Felix G. Gassert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: A systematic review and meta-analysis
Yitao Mao et al.
SCIENTIFIC REPORTS (2020)
Follow-Up 18F-FDG PET/CT versus Contrast-Enhanced CT after Ablation of Liver Metastases of Colorectal Carcinoma-A Cost-Effectiveness Analysis
Moritz L. Schnitzer et al.
CANCERS (2020)
Trends in the Incidence of Pancreatic Adenocarcinoma in All 50 United States Examined Through an Age-Period-Cohort Analysis
Wilson L. da Costa et al.
JNCI CANCER SPECTRUM (2020)
Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma
Hye Jin Kim et al.
CANCER RESEARCH AND TREATMENT (2019)
The Time to and Type of Pancreatic Cancer Recurrence after Surgical Resection: Is Prediction Possible?
Jelena Djokic Kovac et al.
ACADEMIC RADIOLOGY (2019)
Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013
Angela C. Tramontano et al.
MEDICINE (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
Chong Hyun Suh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
David Cameron et al.
GLOBAL HEALTH ACTION (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model
Sopany Saing et al.
ANZ JOURNAL OF SURGERY (2018)
Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta- analysis of sensitivity, specificity and diagnostic accuracy
James Toft et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Pancreatic Cancer Surgery The New R-status Counts
Oliver Strobel et al.
ANNALS OF SURGERY (2017)
Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
Amudhan Pugalenthi et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Assessment of health care cost for complex surgical patients: review of cost, re-imbursement and revenue involved in pancreatic surgery at a high-volume academic medical centre
Swapnil D. Kachare et al.
HPB (2015)
Cost effectiveness after a pancreaticoduodenectomy: bolstering the volume argument
Jeffrey M. Sutton et al.
HPB (2014)
Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT
Y. K. Kim et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Costs and Trends in Pancreatic Cancer Treatment
Caitriona B. O'Neill et al.
CANCER (2012)
Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: A meta-analysis
YaoJun Zhang et al.
PANCREATOLOGY (2012)
Diagnosis of Colorectal Hepatic Metastases: Comparison of Contrast-Enhanced CT, Contrast-Enhanced US, Superparamagnetic Iron Oxide-Enhanced MRI, and Gadoxetic Acid-Enhanced MRI
Ali Muhi et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical and Patient-Reported Outcomes After Pancreatoduodenectomy for Different Diseases A Follow-Up Study
Raffaele Pezzilli et al.
PANCREAS (2011)
Detection of Pancreatic Carcinoma and Liver Metastases with Gadoxetic Acid-enhanced MR Imaging: Comparison with Contrast-enhanced Multi-Detector Row CT
Utaroh Motosugi et al.
RADIOLOGY (2011)
INTERNATIONAL SURVEY ON WILLINGNESS-TO-PAY (WTP) FOR ONE ADDITIONAL QALY GAINED: WHAT IS THE THRESHOLD OF COST EFFECTIVENESS?
Takeru Shiroiwa et al.
HEALTH ECONOMICS (2010)
Focal liver lesion detection and characterization with diffusion-weighted MR imaging: Comparison with standard breath-hold T2-weighted imaging
Tejas Parikh et al.
RADIOLOGY (2008)
Pancreatic resection in Veterans Affairs and selected university medical centers: Results of the Patient Safety in Surgery Study
Robert E. Glasgow et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness
S Heinrich et al.
ANNALS OF SURGERY (2005)
Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma -: A meta-analysis
S Bipat et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2005)
Pancreatic cancer: Cost-effectiveness of imaging technologies for assessing resectability
PM McMahon et al.
RADIOLOGY (2001)
Quality of life and outcomes after pancreaticoduodenectomy
JJ Huang et al.
ANNALS OF SURGERY (2000)